These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 22777229

  • 1. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study.
    Kircik LH.
    J Drugs Dermatol; 2012 Jul; 11(7):858-60. PubMed ID: 22777229
    [Abstract] [Full Text] [Related]

  • 2. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
    Parish LC, Jorizzo JL, Breton JJ, Hirman JW, Scangarella NE, Shawar RM, White SM, SB275833/032 Study Team.
    J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
    Tanus T, Scangarella-Oman NE, Dalessandro M, Li G, Breton JJ, Tomayko JF.
    Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
    [Abstract] [Full Text] [Related]

  • 4. The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study.
    Tomayko JF, Li G, Breton JJ, Scangarella-Oman N, Dalessandro M, Martin M.
    Adv Skin Wound Care; 2013 Mar; 26(3):113-21. PubMed ID: 23426412
    [Abstract] [Full Text] [Related]

  • 5. Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis?
    Moody MN, Morrison LK, Tyring SK.
    Skin Therapy Lett; 2010 Jan; 15(1):1-4. PubMed ID: 20066388
    [Abstract] [Full Text] [Related]

  • 6. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, Yi D, Zhao B.
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [Abstract] [Full Text] [Related]

  • 7. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
    Scangarella-Oman NE, Shawar RM, Bouchillon S, Hoban D.
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.
    Koning S, van der Wouden JC, Chosidow O, Twynholm M, Singh KP, Scangarella N, Oranje AP.
    Br J Dermatol; 2008 May; 158(5):1077-82. PubMed ID: 18341664
    [Abstract] [Full Text] [Related]

  • 9. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP, Chosidow O, Sacchidanand S, Todd G, Singh K, Scangarella N, Shawar R, Twynholm M, TOC100224 Study Team.
    Dermatology; 2007 May; 215(4):331-40. PubMed ID: 17911992
    [Abstract] [Full Text] [Related]

  • 10. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
    Canpolat F, Erkoçoğlu M, Tezer H, Kocabaş CN, Kandi B.
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre, Brazil.
    Petry V, Lipnharski C, Bessa GR, Silveira VB, Weber MB, Bonamigo RR, d'Azevedo PA.
    Int J Dermatol; 2014 Jun; 53(6):731-5. PubMed ID: 24168078
    [Abstract] [Full Text] [Related]

  • 12. Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections.
    Parish LC, Parish JL.
    Drugs Today (Barc); 2008 Feb; 44(2):91-102. PubMed ID: 18389088
    [Abstract] [Full Text] [Related]

  • 13. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.
    Yang LP, Keam SJ.
    Drugs; 2008 Feb; 68(6):855-73. PubMed ID: 18416589
    [Abstract] [Full Text] [Related]

  • 14. Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.
    Matiz C, Tom WL, Eichenfield LF, Pong A, Friedlander SF.
    Pediatr Dermatol; 2011 Feb; 28(1):6-11. PubMed ID: 21070347
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
    Kedzierska A, Kapińska-Mrowiecka M, Czubak-Macugowska M, Wójcik K, Kedzierska J.
    Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility of Staphylococcus aureus in children with atopic dermatitis.
    Tang CS, Wang CC, Huang CF, Chen SJ, Tseng MH, Lo WT.
    Pediatr Int; 2011 Jun; 53(3):363-7. PubMed ID: 20723106
    [Abstract] [Full Text] [Related]

  • 18. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.
    Rittenhouse S, Singley C, Hoover J, Page R, Payne D.
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3886-8. PubMed ID: 17065626
    [Abstract] [Full Text] [Related]

  • 19. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.
    Jacobs MR.
    Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900
    [Abstract] [Full Text] [Related]

  • 20. Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin.
    Free A, Roth E, Dalessandro M, Hiram J, Scangarella N, Shawar R, White S, SB275833/030 Study Group.
    Skinmed; 2006 Dec; 5(5):224-32. PubMed ID: 16957433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.